Perhydroazulene-based liquid-crystalline materials with smectic phases

Introduction

Liquid crystals for display applications have to fulfill a complex, interdependent set of properties [1]. First of all, they must display a broad nematic phase, typically ranging from −30 °C to +80 °C. The absolute value for the dielectric anisotropy Δε should be large in order to decrease the operating voltage, since this will lower power consumption. The rotational viscosity γ₁ should be as low as possible to allow fast switching, and the birefringence Δn has to be adjusted to fit the precise display configuration, in particular the cell gap. In the molecular design of new liquid crystals, electro-optical properties can now be predicted quite precisely based on molecular modeling [1,2]. However, full evaluation of the value of a new structure is still only possible after synthesis. In the past few years many attempts have been made to improve the properties of calamitic liquid crystals [3-8]. However, there is still a growing need for more advanced materials to be synthesized and tested for the desired features of the displays. Moreover, the properties of the LC materials required for applications in LCDs are achieved by mixture formulation of various components, including about 15–20 individual LC molecules.

The nematic (N) liquid crystal phase, with its orientational order only, is the most important mesophase; it is used in almost all commercially available LC displays. On the other hand, the smectic (Sm) LC phases, with their orientational order, have found little commercially successful applications. So far, an enormous amount of experimental and theoretical work exists in the literature concerning the nematic liquid crystals [1-8], whereas smectic liquid crystals have not been studied to the same extent, although recently they have attracted considerable interest [9-12]. It has also been demonstrated that by modification of the basic structures a wide range of properties affecting the liquid crystal behavior of these materials can be changed. The core units presently used in most of the calamitic LCs are cyclohexane, phenylcyclohexane, etc. We previously introduced [13] a completely new core unit: the perhydroazulene ring system. This system provides a segment that may align in such a way that the long molecular axes are parallel, with the capability to induce anisotropy, whereas if we introduce terminal chains, they can provide flexibility to stabilize the molecular alignment within the mesophase. Such terminal chains can either be nonpolar straight alkyl chains or carry a polar substituent. Such molecules may form both nematic and smectic mesophases depending upon the type of substituents and their substituent combinations, as well as on the stereochemistry at their central junction and the relative orientation of the respective substituents.

Hydroazulene-based liquid-crystal molecules are expected to show mesogenic behavior if linearity exists in the system. Such linearity can be achieved by the introduction of terminal groups preferentially in trans- or anti-fashion. We previously employed a ring expansion strategy for the synthesis of the perhydroazulene core and were able to also purify several of our carbene adducts by way of HPLC [14]. If we start our synthesis by the introduction of relevant terminal groups into the isomer that can provide the material with trans-stereochemistry, the resulting derivatives could reveal mesogenic behavior as expected (Figure 1).

In the present contribution, we report on the synthesis and mesogenic properties of materials containing a perhydroazulene core system and discuss the dependence of the LC properties of these materials on the stereochemistry of this core. Resulting from our investigations, we describe here that the perhydroazulene core system, having substituents with only trans orientation, provides mesogenic properties. To the best of our knowledge, such studies are so far absent from the literature with regard to hydroazulene-based smectic liquid-crystalline materials.

Results and Discussion

The synthesis of exo-isomers 1a and 1b (Scheme 1) has already been reported [14]. Both isomers were purified through reversed-phase HPLC, obtained in >98% purity, and characterized by NMR spectroscopy as well as by their other analytical data [14]. The NMR data of 1a and 1b indicate that methylene groups in the five-membered ring carry pairwise enantiotopic and diastereotopic H-atoms; enantiotopic with respect to the internal mirror plane, diastereotopic with respect to above and below the plane of the molecules. A triplet at 1.40 ppm for 1a and 1.34 ppm for 1b with almost the same coupling constant (4.3 Hz) between the H-atoms at the cyclopropyl ring indicates an anti-relation between the ethoxycarbonyl group and the cyclohexene ring.

The isomers 1a and 1b were subsequently subjected to a ring-opening reaction to afford the cycloheptatrienes 4a and 4b. In a first step, the isomers 1 were first brominated in carbon tetrachloride [15], to produce the dibromides 2a and 2b. After the complete addition of bromine, triethylamine was added slowly, resulting in triethylamine hydrobromide and the formation of the norcaradiene intermediates 3a and 3b in situ. These were subsequently converted by overnight heating into the cycloheptatrienes 4a and 4b as slightly colored liquids, by an electrocyclic ring-opening mechanism and a subsequent base-catalyzed prototropic shift, as described for analogous compounds [13]. In principle, the double bonds in the seven-membered rings of these derivatives could be arranged in a different fashion through the so-called Berson–Willcott rearrangement [16] or by 1,5-H shift processes. The exclusive generation of the particular isomers shown is presumably associated with their greater thermodynamic stability. With a double bond at the ring junction, the resulting isomer possesses the most highly substituted double bond possible (Scheme 2).

The two diastereomers 4a and 4b were separated and their structures were established by 1D and 2D NMR methods in addition to other analytical tools. The multiplet at 2.66 ppm in the ¹H NMR spectrum for 6-H, doublets at 6.15–6.19 ppm with the coupling constant 9.1 Hz for 4/8-H and a singlet at 141.79 ppm in the ¹³C NMR spectrum for C-3a/8a indicated the formation of 4a and 4b. The orientation of the terminal groups and position of the double bonds in isomers similar to 4a and 4b was established by analysis of the X-ray structures of their corresponding acids [14].

Continuing the synthesis, the precursors 4a and 4b were hydrogenated in the presence of Pd/C, and ethyl acetate as solvent which resulted in the completely saturated perhydroazulene systems 5a and 5b. It is important to note that, in addition to 5a and 5b, we also observed the presence of one additional isomer (<5%) in both cases in the GC-chromatogram. The formation of such an isomer from pure 4a or 4b can only be rationalized if catalytic hydrogenation results in an isomer with a trans-ring junction at the 3a/8a-position, as described previously [13,14]. However, in the present investigation, we could not completely purify this minor isomer in order to establish its exact stereochemical structure. Based on the full characterization of 4a and 4b by spectroscopic, analytical and X-ray data, the structures of the perhydroazulene systems 5a and 5b were elucidated. The disappearance of doublets at 6.1 ppm with coupling constants of 9.1 Hz for the 4/8 protons in 4a and 4b, and the appearance of multiplets for these protons, indicated the formation of 5a and 5b. Complete NMR (1D, 2D) as well as other analytical data of the above isomers can be found separately in the experimental section. In order to gain additional insight into the structures of the above esters (5a, 5b) and to confirm their stereochemistry, their hydrolysis [17] was carried out in the presence of NaOH and MeOH. Acids 6a and 6b were obtained in the form of colorless solids, which were recrystallized from hexane/dichloromethane. Although the single crystals obtained were not suitable for a high-quality X-ray analysis, we could compare the NMR data of the resulting acids with the data of similar acids [13]. Based on this comparison, we established that the protons at 3a and 8a point in the same direction leading to cis-fused systems. The cycloheptane rings display very similar conformations, with local mirror symmetry through C6 and the midpoint of the C3a–C8a bond. Hydrogen bonding between the acids produces the usual dimeric forms. The complete analytical and spectroscopic data of 6a and 6b (Scheme 3) can be found in the experimental section.

In a final step, esterification [18] of acids 6a and 6b was carried out in order to investigate the effect of stereochemistry on the liquid-crystalline properties in the resulting esters. We selected two different phenols for this esterification step, one with a nonpolar end group, an alkyl chain, and the other with a polar end group, a cyano moiety. The newly synthesized derivatives 8a and 8b (Scheme 4) and 10a and 10b (Scheme 5) were carefully purified and characterized through 1D and 2D NMR as well as through their other analytical data.

Investigation of the mesogenic properties of the target compounds 8a, 8b, 10a and 10b

Investigation of the materials synthesized above for their phase-transition behavior showed that compounds 8a and 10a, with the ester and alkyl groups in 6- and 2-positions oriented cis to each other, do not display mesogenic behavior, and in both cases we see a clear crystal-to-isotropic transition (Table 1). However, compounds 8b and 10b with trans-orientations in the 6- and 2-positions showed several liquid-crystalline phases over a wide temperature range. Variable-temperature optical polarized microscopy (vt-OPM) and differential scanning calorimetry (DSC) measurements revealed that compound 8b is converted into a SmC phase at ~28 °C and converts into a short-temperature-range SmA and N phase at ~101 °C and 107 °C, respectively. The conversion of the nematic phase to the isotropic phase in the case of 8b was observed at 117 °C. Similar investigations on phase transitions of compound 10b revealed that this material melts into a SmC phase at a much higher temperature, i.e., ~94 °C, compared to 8b. This mesophase was stable up to 244 °C at which it converted into a short-range SmA phase followed by transitions into the nematic and isotropic phases at 253 °C and 266 °C, respectively. Appearance of transitions at much higher temperatures in case of 10b compared to 8b could be associated with the chemical structures of both compounds. In the case of 8b, the presence of only one aromatic ring with a short alky chain at the ester side could result in a lower melting range, while the presence of cyanobiphenyl in the case of 10b could cause its higher melting behavior.

Conclusion

We have synthesized new liquid-crystalline materials with a perhydroazulene core and investigated their stereochemistry by advanced NMR spectroscopic methods. On the basis of the concept that linearity in these molecules results in liquid-crystalline phases, we present data here on smectic as well as nematic phases that are observed in isomers with only trans-positioned terminal groups. We have also shown that by changing terminal group(s), a broad range of LC phases results, characterized by the transition temperatures of smectic phases in those isomers that carry a polar terminal group compared to those with a nonpolar terminal group. We have also fully described the synthesis of acid 6b, which is the key intermediate, from the starting material 1b in three steps with a total average yield of about 72%.

Experimental

TLC: Precoated plastic plates, PolyGram Sil G/UV₂₅₄. Column chromatography: Silica gel 60 (70–230 mesh) Merck (Darmstadt). Mp below 200 °C: Büchi 510 melting-point apparatus, above 200 °C: Kofler-Heiztischmikroskop, uncorrected. ¹H and ¹³C NMR: Bruker DRX-400, ¹H NMR (400.1 MHz); ¹³C NMR (100.6 MHz); chemical shifts (δ) are expressed in parts per million (ppm) downfield from tetramethylsilane or by using the residual nondeuterated solvent as internal standards (CDCl₃: ¹H: δ 7.26; ¹³C: δ 77.00). IR: Nicolet 320 FT-IR and Bruker Tensor 27 spectrometer. Samples were prepared either as KBr pellets or as thin films. UV: In acetonitrile and methanol with a Beckman UV 5230 or a HP 8452A Diode Array spectrophotometer. MS: Finnigan MAT 8430 using the electron ionization method (EI, 70 eV). CH₂Cl₂ and Et₃N were distilled from CaH₂ under nitrogen, while all other chemicals were of reagent quality and used as obtained from the suppliers. Reactions were carried out under dried argon when necessary. The experimental procedures for the preparation of 4a, 4b, 5a, 5b as well as 6a, 6b are essentially the same as described previously [13].

Ethyl 2-octyl-1,2,3,6-tetrahydro-6-azulenecarboxylate (4a, 4b): Ethyl 4-octyl-1,1a,2,3,4,5,6,6a-octahydrocyclopropa[f]indene-1-carboxylate (1a, 0.8 g, 2.51 mmol) was dissolved in CCl₄ (30 mL), and the solution was cooled in an ice bath. Bromine (0.41 g, 2.51 mmol) dissolved in CCl₄ (5 mL) was added dropwise under stirring. When the addition was complete, triethylamine (1.12 g, 11.18 mmol) was added. Triethylamine hydrobromide began to form immediately. The mixture was heated under reflux for 18 h. After being cooled, the hydrobromide was filtered off. The filtrate was evaporated and the resulting oil partitioned between benzene and dilute aqueous acid (HCl). The benzene layer was washed with water and dried with MgSO₄ and filtered to obtain the crude product. After solvent removal in vacuo, the product was purified by column chromatography on silica gel with dichloromethane and pentane (8:2) as eluents, to yield 4a as light-bluish liquid (0.5 g, ~58%). Compound 4b, also obtained as a light-bluish liquid (56% yield), was synthesized by the same procedure from 1b.

Compound 4a: Bp 134–136 °C/5 Torr; ¹H NMR (400.1 MHz, CDCl₃) δ 0.86 (t, ³J = 7.07 Hz, 3H, 19-H), 1.28 (t, ³J = 7.14 Hz, 3H, 11-H), 1.22–1.26 (m, 14H, 12-H, 18-H), 2.21 (m, 1H, 2-H), 2.32–2.41/2.77–2.83 (m, 4H, 1-H, 3-H), 2.66 (m, 1H, 6-H), 4.25 (q, ³J = 7.13 Hz, 2H, 10-H), 5.32–5.39 (m, 2H, 5-H, 7-H), 6.15–6.19 (2 × d, ³J = 9.1 Hz, 2H, 4-H, 8-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 14.09/14.24 (2 × q, C-11, C-19), 22.67 (t, C-18), 28.34 (t, C-13), 29.32, 29.63, 29.80 (3 × t, C-14, C-16), 31.90 (t, C-17), 35.97 (t, C-12), 37.34 (d, C-2), 42.82 (2 × t, C-1, C-3), 45.22 (d, C-6), 60.92 (t, C-10), 115.99, 116.65 (2 × d, C-5, C-7), 125.31, 125.45 (2 × d, C-4, C-8), 141.79 (s, C-3a, C-8a), 173.24 (s, C-9); IR (film) : 2956 (m, CH-stretch), 173 (s, C=O), 1612 (w) cm⁻¹; UV (CH₃CN) λ_max nm (log ε): 228 (3.77), 236 (3.68), 246 (3.66), 264 (3.50); MS (EI, 70 eV) m/z (%): 316 (9) [M⁺], 243 (100) [M⁺ − C₃H₅O₂], 129 (10) [243 − C₈H₁₈]; HRMS: calcd for C₂₁H₃₂NaO₂, 339.229999; found, 339.22998 ± 0.07 ppm.

Compound 4b: Bp 135–137 °C/5 Torr; ¹H NMR (400.1 MHz, CDCl₃) δ 0.86 (t, ³J = 6.60 Hz, 3H, 19-H), 1.28 (t, ³J = 7.13 Hz, 3H, 11-H), 1.25–1.26 (m, 14H, 12-H, 18-H), 2.21 (m, 1H, 2-H), 2.31–2.41/2.77–2.83 (m, 4H, 1-H, 3-H), 2.68 (m, 1H, 6-H), 4.22 (q, ³J = 7.12 Hz, 2H, 10-H), 5.32–5.39 (m, 2H, 5-H, 7-H), 6.15–6.19 (2 × d, ³J = 9.13 Hz, 2H, 4-H, 8-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 14.08/14.23 (2 × q, C-11, C-19), 22.65 (t, C-18), 28.20 (t, C-13), 29.30, 29.62, 29.79 (3 × t, C-14, C-16), 31.88 (t, C-17), 36.16 (t, C-12), 37.79 (d, C-2), 42.99 (2 × t, C-1, C-3), 45.21 (d, C-6), 60.91 (t, C-10), 115.96, 116.63 (2 × d, C-5, C-7), 125.29, 125.44 (2 × d, C-4, C-8), 141.68 (s, C-3a, C-8a), 173.24 (s, C-9); IR (film) : 2958 (m, CH-stretch), 1738 (s, C=O), 1610 (w), 1465 (w) cm⁻¹; UV (CH₃CN) λ_max nm (log ε): 228 (3.77), 236 (3.68), 246 (3.66), 264 (3.50); MS (EI, 70 eV) m/z (%): 316 (9) [M⁺], 243 (100) [M⁺ − C₃H₅O₂], 129 (10) [243 − C₈H₁₈]; HRMS: calcd for C₂₁H₃₂NaO₂, 339.229999; found, 339.23009 ± 0.27 ppm.

Ethyl 2-octylperhydro-6-azulenecarboxylate (5a and 5b): Ethyl 2-octyl-1,2,3,6-tetrahydro-6-azulenecarboxylate (4a, 1.3 g, 4.11 mmol) was dissolved in ethyl acetate (100 mL) in a 250 mL flask and Pd/C (0.33 g) was added to the mixture. A stream of H₂ was blown through the suspension after evacuation, and the flask was shaken for 2 h in a hydrogen atmosphere. The mixture was filtered to remove the catalyst and the solvent was evaporated to yield the product in quantitative yield as a colorless liquid. GC analysis indicated the presence of another isomer (about 15%), which could not be separated completely by column chromatography on silica gel, whereas the major isomer (>82%) was separated by elution with pentane, by increasing its polarity through the addition of dichloromethane (~50%). The major product was found to be the one with the cis-fused ring system, as expected (5a, 1.06 g, ~80%); this eluted first from the column followed by the isomer with the trans-fused system (always containing traces of the cis-fused derivative). Compound 5a: Bp 145–150 °C/5 Torr; ¹H NMR (400.1 MHz, CDCl₃) δ 0.85 (t, ³J = 6.84 Hz, 3H, 19-H), 1.23 (t, ³J = 7.14 Hz, 3H, 14-H), 1.21–1.22 (m, 14H, side chain protons), 1.45–1.50 (m, 2H, 3a-H, 8a-H), 1.48–1.53 (m, 4H, 4-H, 8-H), 1.60–1.67 (m, 1H, 2-H), 0.82/1.81 (m, 4H, 1-H, 3-H), 2.00–2.09 (m, 4H, 5-H, 7-H), 2.57–2.62 (m, 1H, 6-H), 4.11 (q, ³J = 7.12 Hz, 2H, 10-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 14.09, 14.28 (2 × q, C-11, C-19), 22.67 (t, C-18), 28.73 (t, C-13), 28.79 (2 × t, C-4, C-8), 29.82 (2 × d, C-5, C-7), 29.33, 29.65, 29.97 (3 × t, C-14, C-15, C-16), 31.91 (t, C-17), 35.52 (t, C-12), 40.23 (d, C-2), 41.69 (2 × t, C-1, C-3), 42.12 (2 × t, C-3a, C-8a), 43.46 (d, C-6), 59.98 (t, C-10), 176.12 (s, C=O); IR (film) : 2932 (s, CH-stretch), 1732 (s, C=O), 1463, 1450 (w) cm⁻¹; UV (CH₃CN) λ_max nm (log ε): 204 (2.92), 216 (2.55), 234 (2.15), 284 (1.86); MS (EI, 70 eV) m/z (%): 322 (100) [M⁺], 307 (17) [M⁺ − CH₃], 293 (33) [M⁺ − C₂H₅], 276 (20) [M⁺ − C₂H₆O], 248 (16) [M⁺ − C₃H₆O₂], 206 (55) [M⁺ − C₈H₁₇], 135 (42) [209 − C₃H₆O₂]; HRMS: calcd for C₂₁H₃₈O₂, 322.287178; found, 322.287430 ± 0.78 ppm.

Compound 5b: Compound 5b was obtained from 4b by the same procedure as described for 5a in 77% yield as a colorless liquid. bp 147–151 °C/5 Torr; ¹H NMR (400.1 MHz, CDCl₃) δ 0.86 (t, ³J = 6.91 Hz, 3H, 19-H), 1.25 (t, ³J = 7.12 Hz, 3H, 14-H), 1.21–1.24 (m, 14H, side chain protons), 1.45–1.55 (m, 2H, 3a-H, 8a-H), 1.49 (m, 4H, 4-H, 8-H), 1.68 (m, 1H, 2-H), 0.86/1.92 (m, 4H, 1-H, 3-H), 2.13 (m, 4H, 5-H, 7-H), 2.55 (m, 1H, 6-H), 4.12 (q, ³J = 7.11 Hz, 2H, 10-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 14.11, 14.21 (2 × q, C-11, C-19), 22.67 (t, C-18), 28.73 (t, C-13), 28.86 (2 × t, C-4, C-8), 29.57 (2 × d, C-5, C-7), 29.33, 29.65, 29.97 (3 × t, C-14, C-15,C-16), 31.91 (t, C-17), 35.52 (t, C-12), 41.12 (d, C-2), 41.69 (2 × t, C-1, C-3), 41.90 (2 × t, C-3a, C-8a), 46.61 (d, C-6), 59.98 (t, C-10), 176.31 (s, C=O); IR (film) : 2932 (s, CH-stretch), 1732 (s, C=O), 1463, 1450 (w) cm⁻¹; UV (CH₃CN) λ_max nm (log ε): 204 (2.92), 216 (2.55), 234 (2.15), 284 (1.86); MS (EI, 70 eV) m/z (%): 322 (100) [M⁺], 307 (18) [M⁺ − CH₃], 293 (35) [M⁺ − C₂H₅], 276 (25) [M⁺ − C₂H₆O], 248 (10) [M⁺ − C₃H₆O₂], 206 (53) [M⁺ − C₈H₁₇], 135 (45) [209 − C₃H₆O₂]; HRMS: calcd for C₂₁H₃₈O₂, 322.287176; found, 322.287435 ± 0.51 ppm.

2-Octylperhydro-6-azulenecarboxylic acid (6a): In a 250 mL round-bottomed flask EtOH (60 mL) and aqueous 1 M NaOH (36 mL) were placed. The solution was left to stir for a while and 5a (300 mg, 0.93 mmol) was added slowly; the mixture was kept at room temperature and stirred for 4–6 h. When TLC analysis showed no more starting materials to be present, the mixture was acidified with 1 M HCl. The EtOH was evaporated and the residual aqueous solution was extracted twice with ethyl acetate and once with dichloromethane_. The organic phases were combined, washed with water, and dried (MgSO₄). The solvent was evaporated and the residue purified by column chromatography on silica gel by first eluting the impurities with dichloromethane and finally washing the column with Et₂O to yield 240 mg (87%) of 6a as a colorless solid. Acid 6b was obtained from ester 5b by the same procedure as for 6a in 84% yield (230 mg), also as a colorless solid.

Compound 6a: Mp 102–104 °C; ¹H NMR (400.1 MHz, CDCl₃) δ 0.85 (t, ³J = 6.91 Hz, 3H, 17-H), 1.23 (m, 14H, side chain protons), 1.55 (m, 2H, 3a-H, 8a-H), 1.58 (m, 4H, 4-H, 8-H), 1.71 (m, 1H, 2-H), 0.78/2.22 (m, 4H, 1-H, 3-H), 2.15–2.58 (m, 4H, 5-H, 7-H), 2.69 (m, 1H, 6-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 14.11 (q, C-17), 22.66 (t, C-16), 28.72 (t, C-11), 29.41 (2 × t, C-4, C-8), 29.68, 29.90, 29.99 (3 × t, C-12, C-13, C-14), 31.08 (t, C-15), 31.93 (2 × t, C-5, C-7), 32.07 (t, C-10), 37.67 (d, C-2), 41.21 (2 × d, C-3a, C-8a), 41.43 (2 × t, C-1, C-3), 43.54 (d, C-6), 182.23 (s, C=O); MS (EI, 70 eV) m/z (%): 294 (40) [M⁺], 276 (18) [M⁺ − H₂O], 265 (25) [M⁺ − C₂H₅], 181 (51) [M⁺ − C₈H₁₇], 179 (100) [181 − H₂], 133 (52) [179 − H₂CO₂].

Compound 6b: Mp 103–106 °C; ¹H NMR (400.1 MHz, CDCl₃) δ 0.80 (t, ³J = 6.80 Hz, 3H, 17-H), 1.23 (m, 14H, side chain protons), 1.41–1.54 (m, 2H, 3a-H, 8a-H), 1.47–1.57 (m, 4H, 4-H, 8-H), 1.63–1.70 (m, 1H, 2-H), 0.67–0.70/1.83–2.10 (m, 4H, 1-H, 3-H), 2.15–2.58 (m, 4H, 5-H, 7-H), 2.67–2.69 (m, 1H, 6-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 14.09 (q, C-17), 22.67 (t, C-16), 28.72 (t, C-11), 29.35 (2 × t, C-4, C-8), 29.68, 29.90, 29.99 (3 × t, C-12, C-13, C-14), 31.08 (t, C-15), 31.93 (2 × t, C-5, C-7), 32.07 (t, C-10), 37.77 (d, C-2), 40.25 (2 × d, C-3a, C-8a), 42.48 (2 × t, C-1, C-3), 45.60 (d, C-6), 182.54 (s, C=O); MS (EI, 70 eV) m/z (%): 294 (36) [M⁺], 276 (14) [M⁺ − H₂O], 265 (26) [M⁺ − C₂H₅], 181 (54) [M⁺ − C₈H₁₇], 179 (100) [181 − H₂], 133 (52) [179 − H₂CO₂].

General procedure for esterification of 8a, 8b and 10a, 10b. Thionyl chloride (0.021 mL, 0.28 mmol) was added to a solution of 4-(N,N-dimethylamino)pyridine (DMAP, 34 mg, 0.27 mmol) in dichloromethane (5 mL) at −20 °C. Acid 6a or 6b (65 mg, 0.22 mmol) was added and the resulting solution was stirred for 1 h. Then, DMAP (34 mg, 0.27 mmol) and the phenol 7 (33.0 mg, 0.22 mmol) or 9 (43.0 mg, 0.22 mmol) were added and stirring was continued for another 1 h. The mixture was washed with water (5 mL) and the organic layer was separated and dried with sodium sulfate. The solvent was evaporated, and the remaining residue was separated by silica gel column chromatography, eluting with dichloromethane and pentane (1:1) to give the esters 8a, 8b or 10a, 10b as colorless solids.

Compound 8a: Mp 41–43 °C; ¹H NMR (400.1 MHz, CDCl₃) δ 0.86 (t, ³J = 6.95 Hz, 3H, 27-H), 0.90 (t, ³J = 7.35 Hz, 3H, 19-H), 1.24 (m, 14H, side chain protons), 1.30–1.35 (m, 2H, 17-H), 1.53–1.60 (m, 6H, 4-H, 8-H, 18-H), 1.63–1.66 (m, 1H, 2-H), 0.82/1.86 (m, 4H, 1-H, 3-H), 2.08–2.24 (m, 2H, 3a-H, 8a-H), 2.20–2.24 (m, 4H, 5-H, 7-H), 2.58 (t, ³J = 7.72 Hz, 2H, 16-H), 2.87–2.90 (m, 1H, 6-H), 6.93 (d, ³J = 11.10 Hz, 11-H, 15-H), 7.15 (d, ³J = 11.06 Hz, 2H, 12-H, 14-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 13.67, 13.87 (2 × q, C-19, C-27), 22.03 (t, C-18), 22.44 (t, C-26), 28.50 (t, C-21), 28.53 (2 × t, C-4, C-8), 29.47 (2 × t, C-5, C-7), 29.10, 29.41, 29.74 (3 × t, C-22, C-23, C-24), 31.68 (t, C-25), 33.37 (t, C-20), 34.78 (t, C-16), 35.28 (t, C-17), 40.03 (d, C-2), 41.52 (2 × t, C-1, C-3), 41.80 (2 × d, C-3a, C-8a), 43.30 (d, C-6), 120.97 (2 × d, C-11, C-15), 128.94 (2 × d, C-12, C-14), 139.91 (s, C-13), 148.62 (s, C-10), 174.53 (s, C=O); IR (film) : 2932 (s, CH-stretch), 1732 (s, C=O), 1463, 1450 (w), 1376, 1221 (w), 1183, 1143 (m), 1095, 1046, 1033 (w) cm⁻¹; UV (CH₃CN) λ_max nm (log ε): 204 (2.92), 216 (2.55), 234 (2.15), 284 (1.86), 312 (1.80), 342 (1.64), 374 (1.54); MS (EI, 70 eV) m/z (%): 426 (9) [M⁺], 276 (100) [M⁺ − C₁₀H₁₄O], 249 (17) [276 − CO], 163 (15) [276 − C₈H₁₇], 150 (85) [163 − CH]; HRMS: calcd for C₂₉H₄₆NaO₂, 449.338997; found, 449.338715 ± 0.63 ppm.

Compound 8b: ¹H NMR (400.1 MHz, CDCl₃) δ 0.86 (t, ³J = 6.97 Hz, 3H, 27-H), 0.90 (t, ³J = 7.35 Hz, 3H, 19-H), 1.24 (m, 14H, side chain protons), 1.31–1.36 (m, 2H, 17-H), 1.51–1.58/1.70–1.74 (m, 6H, 4-H, 8-H, 18-H), 1.64–1.67 (m, 1H, 2-H), 0.77/1.97 (m, 4H, 1-H, 3-H), 2.08–2.13 (m, 2H, 3a-H, 8a-H), 1.53/2.22 (m, 4H, 5-H, 7-H), 2.46–2.52 (m, 1H, 6-H), 2.57 (t, ³J = 7.73 Hz, 2H, 16-H), 6.93 (d, ³J = 8.48 Hz, 11-H, 15-H), 7.13 (d, ³J = 8.50 Hz, 2H, 12-H, 14-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 13.69, 13.89 (2 × q, C-19, C-27), 22.07 (t, C-18), 22.46 (t, C-26), 28.50 (t, C-21), 29.12, 29.43, 29.76 (3 × t, C-22, C-23, C-24), 30.90 (2 × t, C-4, C-8), 31.70 (t, C-25), 32.02 (2 × t, C-5, C-7), 33.37 (t, C-20), 34.80 (t, C-17), 35.27 (t, C-16), 40.16 (d, C-2), 42.26 (2 × t, C-1, C-3), 42.86 (2 × d, C-3a, C-8a), 48.33 (d, C-6), 120.79 (2 × d, C-11, C-15), 128.84 (2 × d, C-12, C-14), 139.79 (s, C-13), 148.63 (s, C-10), 174.77 (s, C=O); IR (film) : 2932 (s, CH-stretch), 1732 (s, C=O), 1463, 1450 (w), 1376, 1221 (w), 1183, 1143 (m), 1095, 1046, 1033 (w) cm⁻¹; UV (CH₃CN) λ_max nm (log ε): 204 (2.92), 216 (2.55), 234 (2.15), 284 (1.86), 312 (1.80), 342 (1.64), 374 (1.54); MS (EI, 70 eV) m/z (%): 426 (10) [M⁺], 276 (100) [M⁺ − C₁₀H₁₄O], 249 (21) [276 − CO], 163 (19) [276 − C₈H₁₇], 150 (85) [163 − CH]; HRMS: calcd for C₂₉H₄₆NaO₂, 449.339001; found, 449.339077 ± 0.17 ppm.

Compound 10a: Mp 91–93 °C; ¹H NMR (400.1 MHz, CDCl₃) δ 0.86 (t, ³J = 6.97 Hz, 3H, 30-H), 1.24 (br m, 14H, side chain protons), 1.53 (br m, 4H, 4-H, 8-H), 1.66–1.69 (m, 1H, 2-H), 0.83/1.92 (m, 4H, 1-H, 3-H), 2.10–2.14 (m, 2H, 3a-H, 8a-H), 1.64/2.22 (m, 4H, 5-H, 7-H), 2.93–2.96 (m, 1H, 6-H), 7.17 (d, ³J = 8.73 Hz, 2H, 12-H, 14-H), 7.56 (d, ³J = 8.71 Hz, 2H, 11-H, 15-H), 7.64 (d, ³J = 8.68 Hz, 2H, 17-H, 21-H), 7.70 (d, ³J = 8.58 Hz, 2H, 18-H, 20-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 13.84 (q, C-30), 22.50 (t, C-29), 28.51 (t, C-24), 28.55 (2 × t, C-4, C-8), 29.12, 29.43, 29.75 (3 × t, C-25, C-26, C-27), 29.46 (2 × t, C-5, C-7), 31.70 (t, C-28), 35.30 (t, C-23), 40.06 (d, C-2), 41.54 (2 × t, C-1, C-3), 41.83 (2 × d, C-3a, C-8a), 43.45 (d, C-6), 110.44 (s, C-22), 118.70 (s, C-19), 122.16 (2 × d, C-11,C-15), 127.26 (2 × d, C-12, C-14), 128.00 (2 × d, C-17, C-21), 132.23 (2 × d, C-18, C-20), 136.48 (s, C-13), 144.65 (s, C-16), 151.16 (s, C-10), 174.29 (s, C=O); IR (film) : 2932 (s, CH-stretch), 1732 (s, C=O), 1463, 1450 (w), 1376, 1221 (w), 1183, 1143 (m), 1095, 1046, 1033 (w) cm⁻¹; UV (CH₃CN) λ_max nm (log ε): 204 (2.92), 216 (2.55), 234 (2.15), 284 (1.86), 312 (1.80), 342 (1.64), 374 (1.54); MS (EI, 70 eV) m/z (%): 471 (5) [M⁺], 276 (68) [M⁺ − C₁₃H₉NO], 249 (38) [276 − CO], 135 (49) [249 − C₈H₁₈], 109 (55) [135 − C₂H₂], 95 (100) [109 − CH₂]; HRMS: calcd for C₃₂H₄₁NO₂, 471.313732; found, 471.313327 ± 0.86 ppm.

Compound 10b: ¹H NMR (400.1 MHz, CDCl₃) δ 0.87 (t, ³J = 6.94 Hz, 3H, 30-H), 1.24 (br m, 14H, side chain protons), 1.33/1.77 (m, 4H, 4-H, 8-H), 1.65–1.69 (m, 1H, 2-H), 0.72/1.98 (m, 4H, 1-H, 3-H), 2.10–2.15 (m, 2H, 3a-H, 8a-H), 1.59/2.25 (m, 4H, 5-H, 7-H), 2.51–2.56 (m, 1H, 6-H), 7.14 (d, ³J = 8.70 Hz, 2H, 12-H, 14-H), 7.55 (d, ³J = 8.70 Hz, 2H, 11-H, 15-H), 7.63 (d, ³J = 8.54 Hz, 2H, 17-H, 21-H), 7.70 (d, ³J = 8.53 Hz, 2H, 18-H, 20-H); ¹³C NMR (100.6 MHz, CDCl₃) δ 13.92 (q, C-30), 22.40 (t, C-29), 28.50 (t, C-24), 29.12, 29.43, 29.75 (3 × t, C-25, C-26, C-27), 30.90 (2 × t, C-4, C-8), 31.71 (t, C-28), 31.98 (2 × t, C-5, C-7), 35.27 (t, C-23), 40.01 (d, C-2), 42.32 (2 × t, C-1, C-3), 42.79 (2 × d, C-3a, C-8a), 48.31 (d, C-6), 110.66 (s, C-22), 118.62 (s, C-19), 122.03 (2 × d, C-11, C-15), 127.31 (2 × d, C-12, C-14), 127.96 (2 × d, C-17, C-21), 132.33 (2 × d, C-18, C-20), 136.55 (s, C-13), 144.55 (s, C-16), 151.16 (s, C-10), 174.54 (s, C=O); IR (film) : 2932 (s, CH-stretch), 1732 (s, C=O), 1463, 1450 (w), 1376, 1221 (w), 1183, 1143 (m), 1095, 1046, 1033 (w) cm⁻¹; UV (CH₃CN) λ_max nm (log ε): 204 (2.92), 216 (2.55), 234 (2.15), 284 (1.86), 312 (1.80), 342 (1.64), 374 (1.54); MS (EI, 70 eV) m/z (%): 471 (6) [M⁺], 276 (86) [M⁺ − C₁₃H₉NO], 249 (50) [276 − CO], 135 (56) [249 − C₈H₁₈], 109 (57) [135 − C₂H₂], 95 (100) [109 − CH₂]; HRMS: calcd for C₃₂H₄₁NO₂, 471.313726; found, 471.313482 ± 0.52 ppm.